Evercore ISI lowered the firm’s price target on Stryker to $365 from $370 and keeps an Outperform rating on the shares in an earnings preview for the MedTech, Life Science Tools and Diagnostics group.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SYK:
- Stryker to announce financial results for its second quarter of fiscal year 2024
- Analysts and Technical Indicators Agree: These 3 Stocks Are “Strong Buys” – 6/21/2024
- Needham medtech/diagnostic analyst holds analyst/industry conference call
- Stryker acquires privately held soft tissue fixation products firm Artelon
- ZTS, SYK, LLY: Which Healthcare Stock Is the Best Buy?